Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - 9 months ended Sep. 30, 2017 - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income	Total New Residential Stockholders’ Equity	Noncontrolling Interests in Equity of Consolidated Subsidiaries
Equity, beginning balance (in shares) at Dec. 31, 2016		250,773,117
Equity, beginning balance at Dec. 31, 2016	$ 3,468,177	$ 2,507	$ 2,920,730	$ 210,500	$ 126,363	$ 3,260,100	$ 208,077
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared	(454,877)			(454,877)		(454,877)
Capital contributions	0						0
Capital distributions	(70,493)						(70,493)
Issuance of common stock (in shares)		56,545,787
Issuance of common stock	834,529	$ 566	833,963			834,529
Purchase of noncontrolling interests in the Buyer	(65,860)		9,183			9,183	(75,043)
Other dilution	(4,202)		(4,202)			(4,202)
Director share grants (in shares)		42,405
Director share grants	699	$ 1	698			699	0
Comprehensive income (loss)
Net income (loss)	714,282			669,231		669,231	45,051
Net unrealized gain (loss) on securities	277,805				277,805	277,805
Reclassification of net realized (gain) loss on securities into earnings	(20,856)				(20,856)	(20,856)
Total comprehensive income (loss)	971,231					926,180	45,051
Equity, ending balance (in shares) at Sep. 30, 2017		307,361,309
Equity, ending balance at Sep. 30, 2017	$ 4,679,204	$ 3,074	$ 3,760,372	$ 424,854	$ 383,312	$ 4,571,612	$ 107,592